Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Sarcoma 1 Plasma cell 1 Myeloid 1 Lymphoid 1 Dermatologic 1 Classical hematology 1

Conditions

Neoplasms 1 Febrile Neutropenia 1

Interventions

fludarabine phosphate 58 Cyclophosphamide 54 Epoetin Alfa 43 Cyclosporine 43 Busulfan 43 Peripheral Blood Stem Cell Transplantation 39 Mycophenolic Acid 34 Darbepoetin alfa 33 Antilymphocyte Serum 31 Whole-Body Irradiation 30 Cytarabine 30 Filgrastim 29 Methotrexate 26 Tacrolimus 25 Radiotherapy 25 Melphalan 24 fludarabine 21 Methylprednisolone 17 Cord Blood Stem Cell Transplantation 17 Etoposide 14 Granulocyte Colony-Stimulating Factor 13 Daunorubicin 13 Rivaroxaban 12 apixaban 11 Thiotepa 11 sargramostim 10 epoetin beta 10 Dalteparin 10 eltrombopag 9 Alemtuzumab 9

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Tazobactam × Classical hematology × Clear all

NCT04948463 2026-03-20

ELSA-FN

Murdoch Childrens Research Institute

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡